Kadmon Holdings Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$0.23 |
Market Cap |
$261.55 M |
Shares Outstanding |
129.48 M |
Public Float |
98.28 M |
Address |
450 East 29th Street New York New York 10016 United States |
Employees | - |
Website | http://www.kadmon.com |
Updated | 07/08/2019 |
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. Its products include Ribasphere RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. |